🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

If you missed this, here is the link to the Global Liver Institute, GLI Live #NASHDAY discussion today: "Fighting NASH Around the World". lnkd.in/ggSWNVYR

Looking forward to this discussion on International NASH Day with Medscape Education tomorrow. Hope you can join us. lnkd.in/gdBTBeEN

It was a fabulous discussion! Thank you Roger Green Marko Gina Villiotti Madison NASHKnowledge and Louise Campbell.

Really looking forward to this webinar with Ken Cusi! See you there!

Don't forget to join this important and informative webinar happening tomorrow! Moderators: Naim Alkhouri, Jörn Schattenberg, Nghiem B. Ha Presenters: Dr. Mary E. Rinella, Jeffrey V. Lazarus, Juan Pablo (JP) Arab, MD  Register online at bit.ly/46IpqbE. #LiverTwitter

It’s Black Friday and the only chance you will have to save 75% off the registration for our Second Annual Primary Care NAFLD and NASH Summit. Link to register: pheedloop.com/nash2023/site/… Code for today only is 75BLACKFRIDAY Program info here: nafld-nashpcsummit.ca

😃Honoured to be part of such esteemed faculty at nafld-nashpcsummit.ca! ✳️Fantastic lectures and amazing discussion on the #MASLD global epidemic ✅Thanks to FattyLiverAlliance and Michael Betel for the outstanding program! Mazen Noureddin, MD, MHSc EASLnews CASL Jeffrey V. Lazarus Aleksander Krag

🤝EASL is proud to announce our new patient synergy partnership with FattyLiverAlliance! We share goals to raise awareness, advocate for treatment access, and support research to beat Steatotic Liver Disease. Together, we envision a future where this condition is preventable, and

A great day 1 at Liver Forum 16. No pix during the event, but a few after!

JUST OUT in time for #WorldLiverDay "Use of non-invasive diagnostic tools for metabolic dysfunction-associated steatohepatitis: A qualitative exploration of challenges and barriers" onlinelibrary.wiley.com/doi/10.1111/li… #LiverTwitter

This #worldliverday, help us shape the future of liver care by participating in our #MAFLD #MASH patient survey, as announced in our press release. Share your experiences and help improve treatment and support for all!➡️shorturl.at/AFGJ0 #StepUpForLiverHealth #livertwitter

Hot off the press: Survodutide efficacy in#MASH including both MASH resolution & fibrosis improvement presented ⁦EASL Education⁩ and published ⁦NEJM⁩ today! ⁦Arun J. Sanyal⁩ ⁦Naim Alkhouri⁩ ⁦Ramy Younes, MD, PhD⁩ #livertwitter

. S5 𝗦𝗣𝗘𝗖𝗜𝗔𝗟 𝟭— Reviewing EASL Congress: 𝗠𝗶𝗸𝗲 𝗕𝗲𝘁𝗲𝗹 Roger Green Roger Green speaks with FattyLiverAlliance Founder and CEO Mike Betel Michael Betel on the day before the EASL Congress officially opens. The discussion includes sessions Mike attended and one he

✅Our new paper on #sex differences for #MASLD in people with #HIV! 🟩Lower prevalence of MASLD with #fibrosis in #women than men 🟥Women reach similar levels of liver disease at the perimenopausal age 👉doi.org/10.1111/hiv.13… The CTN+ | Le Réseau+ McGill_DOM CASL HIV Medicine

Really looking forward to this. See you there.

Looking forward to this important chat with Naim Alkhouri tomorrow morning. Join us!

10 days to register and join Naim Alkhouri and I.

What a day in the history of MASH! Reversal of Fibrosis in MASH cirrhotics by 24% (paired) and 17% (ITT) all sig P values. Same for NITs!!!! Happy for the our patients. FGF21s are here to stay!! #livertwitter Elliot Tapper Naim Alkhouri akerotx globenewswire.com/news-release/2…

Huge day for patients with MASH. Our paper in Nature Med showing improved outcomes in cirrhotics w bariatric surgery and then akerotx showing reversal of cirrhosis!! So happy. Mazen Noureddin, MD, MHSc Ali Aminian Arizona Liver Health AASLD Foundation ACG nature.com/articles/s4159…

This will be a GREAT session. Very excited about being on a fantastic panel with great clinicians and friends.